Alcohol, nicotine, and iatrogenic withdrawals in the ICU

Critical Care Medicine

Volumn 41, Issue 9 SUPPL.1, 2013, Pages

  Awissi, Don Kelena ^a   Lebrun, Genevieve ^a   Fagnan, Mylene ^a   Skrobik, Yoanna ^b  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

alcohol; alcohol withdrawal syndrome; critical care; delirium tremens; intensive care; nicotine; nicotine withdrawal

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CLOMETHIAZOLE; CLONIDINE; DEXMEDETOMIDINE; DIAZEPAM; FLUNITRAZEPAM; GLUTAMATE RECEPTOR; GLUTAMIC ACID; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; NICOTINE; OPIATE; PHENOBARBITAL; PLACEBO; PROPOFOL; SEDATIVE AGENT; UNINDEXED DRUG; VALPROIC ACID;

ADRENERGIC STIMULATION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANTICONVULSANT THERAPY; ARTIFICIAL VENTILATION; BLOOD TOXICITY; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DELIRIUM TREMENS; DIAGNOSTIC TEST; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG WITHDRAWAL; DSM-IV; EXTRAVASATION; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HUMAN; HYPOMAGNESEMIA; IATROGENIC DISEASE; INCIDENCE; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER TOXICITY; MORTALITY; NEUROPHYSIOLOGY; NEUROTOXICITY; NEUROTRANSMISSION; NICOTINE REPLACEMENT THERAPY; NICOTINE WITHDRAWAL SYNDROME; NONHUMAN; PATIENT SAFETY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPHYLAXIS; PUBLICATION; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR UPREGULATION; REVIEW; RISK FACTOR; SCREENING TEST; SEIZURE; TOBACCO DEPENDENCE; TRACHEOBRONCHITIS; WITHDRAWAL SYNDROME;

ALCOHOL WITHDRAWAL DELIRIUM; CRITICAL ILLNESS; HUMANS; IATROGENIC DISEASE; INTENSIVE CARE; INTENSIVE CARE UNITS; RISK FACTORS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TOBACCO USE DISORDER; UNITED STATES;

EID: 84883566856     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182a16919     Document Type: Review

References (135)

1. Baldwin WA, Rosenfeld BA, Breslow MJ, et al: Substance abuserelated admissions to adult intensive care. Chest 1993; 103:21-25
2. Clark BJ, Williams A, Cecere Feemster LM, et al: Alcohol screening scores and 90-day outcomes in patients with acute lung injury. Crit Care Med 2013; 41:1518-1525
3. de Wit M, Wan SY, Gill S, et al: Prevalence and impact of alcohol and other drug use disorders on sedation and mechanical ventilation: A retrospective study. BMC Anesthesiol 2007; 7:3
4. National Survery on Drug Use and Health. Available at: https://nsduhweb. rti.org. Accessed April 9, 2013
5. Lawson AK, Wright CV, Fitzgerald LF: The evaluation of sexual harassment litigants: Reducing discrepancies in the diagnosis of posttraumatic stress disorder. Law Hum Behav 2013 [Epub ahead of print]
6. Gacouin A, Legay F, Camus C, et al: At-risk drinkers are at higher risk to acquire a bacterial infection during an intensive care unit stay than abstinent or moderate drinkers. Crit Care Med 2008; 36:1735-1741
7. Suchyta MR, Beck CJ, Key CW, et al: Substance dependence and psychiatric disorders are related to outcomes in a mixed ICU population. Intensive Care Med 2008; 34:2264-2267
8. Uusaro A, Parviainen I, Tenhunen JJ, et al: The proportion of intensive care unit admissions related to alcohol use: A prospective cohort study. Acta Anaesthesiol Scand 2005; 49:1236-1240
9. McKenny M, O'Beirne S, Fagan C, et al: Alcohol-related admissions to an intensive care unit in Dublin. Ir J Med Sci 2010; 179:405-408
10. Monte R, Rabuñal R, Casariego E, et al: Analysis of the factors determining survival of alcoholic withdrawal syndrome patients in a general hospital. Alcohol Alcohol 2010; 45:151-158
11. O'Brien JM Jr, Lu B, Ali NA, et al: Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. Crit Care Med 2007; 35: 345-350
12. Spies CD, Neuner B, Neumann T, et al: Intercurrent complications in chronic alcoholic men admitted to the intensive care unit following trauma. Intensive Care Med 1996; 22:286-293
13. Eggers V, Tio J, Neumann T, et al: Blood alcohol concentration for monitoring ethanol treatment to prevent alcohol withdrawal in the intensive care unit. Intensive Care Med 2002; 28:1475-1482
14. Spies CD, Dubisz N, Funk W, et al: Prophylaxis of alcohol withdrawal syndrome in alcohol-dependent patients admitted to the intensive care unit after tumour resection. Br J Anaesth 1995; 75: 734-739
15. Spies CD, Nordmann A, Brummer G, et al: Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tract. Acta Anaesthesiol Scand 1996; 40: 649-656
16. Spies CD, Otter HE, Hüske B, et al: Alcohol withdrawal severity is decreased by symptom-orientated adjusted bolus therapy in the ICU. Intensive Care Med 2003; 29:2230-2238
17. Chang CC, Kao HK, Huang JJ, et al: Postoperative alcohol withdrawal syndrome and neuropsychological disorder in patients after head and neck cancer ablation followed by microsurgical free tissue transfer. J Reconstr Microsurg 2013; 29:131-136
18. Bard MR, Goettler CE, Toschlog EA, et al: Alcohol withdrawal syndrome: Turning minor injuries into a major problem. J Trauma 2006; 61:1441-1445
19. Jurkovich GJ, Rivara FP, Gurney JG, et al: The effect of acute alcohol intoxication and chronic alcohol abuse on outcome from trauma. JAMA 1993; 270:51-56
20. Eyer F, Schuster T, Felgenhauer N, et al: Risk assessment of moderate to severe alcohol withdrawal-predictors for seizures and delirium tremens in the course of withdrawal. Alcohol Alcohol 2011; 46:427-433
21. Rosenson J, Clements C, Simon B, et al: Phenobarbital for acute alcohol withdrawal: A prospective randomized double-blind placebocontrolled study. J Emerg Med 2013; 44:592-598.e2
22. Lansford CD, Guerriero CH, Kocan MJ, et al: Improved outcomes in patients with head and neck cancer using a standardized care protocol for postoperative alcohol withdrawal. Arch Otolaryngol Head Neck Surg 2008; 134:865-872
23. Masters SB: Chapter 23. The alcohols. In: Basic & Clinical Pharmacology. Twelfth Edition. Katzung BGMS, Trevor AJ (Eds). New York, McGraw-Hill, 2012. Available at: http://www.accesspharmacy. com/content.aspx? aID=55824193. Accessed April 9, 2013
24. Carlson RW, Kumar NN, Wong-Mckinstry E, et al: Alcohol withdrawal syndrome. Crit Care Clin 2012; 28:549-585
25. Schuckit MA: Chapter 23. Ethanol and methanol. In: Goodman & Gilman's the Pharmacological Basis of Therapeutics. Twelfth Edition. Brunton LLCB, Knollmann BC (Eds). New York, McGraw-Hill, 2011. Available at: http://www.accesspharmacy.com/content. aspx?aID=16666094. Accessed April 9, 2013
26. Abrams SM, Pierce DM, Johnston A, et al: Pharmacokinetic interaction between indoramin and ethanol. Hum Toxicol 1989; 8:237-241
27. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC, American Psychiatric Association, 2000
28. Al-Sanouri I, Dikin M, Soubani AO: Critical care aspects of alcohol abuse. South Med J 2005; 98:372-381
29. Turner RC, Lichstein PR, Peden JG Jr, et al: Alcohol withdrawal syndromes: A review of pathophysiology, clinical presentation, and treatment. J Gen Intern Med 1989; 4:432-444
30. Behnke RH: Recognition and management of alcohol withdrawal syndrome. Hosp Pract 1976; 11:79-84
31. Gonzalez-Quintela A, Fernandez-Conde S, Alves MT, et al: Temporal and spatial patterns in the rate of alcohol withdrawal syndrome in a defined community. Alcohol 2011; 45:105-111
32. Sarff M, Gold JA: Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med 2010; 38:S494-S501
33. Hoey LL, Nahum A, Vance-Bryan K: A prospective evaluation of benzodiazepine guidelines in the management of patients hospitalized for alcohol withdrawal. Pharmacotherapy 1994; 14:579-585
34. Thiercelin N, Rabiah Lechevallier Z, Rusch E, et al: Risk factors for delirium tremens: A literature review. Rev Med Interne 2012; 33:18-22
35. Thiercelin N, Andrianirina B, Plat A: Alcohol withdrawal delirium: A retrospective case series of 39 patients. Rev Med Interne 2013; 34:73-77
36. Hoey LL, Nahum A, Vance-Bryan K: A retrospective review and assessment of benzodiazepines in the treatment of alcohol withdrawal in hospitalized patients. Pharmacotherapy 1994; 14: 572-578
37. DeCarolis DD, Rice KL, Ho L, et al: Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit. Pharmacotherapy 2007; 27:510-518
38. Awissi DK, Lebrun G, Coursin DB, et al: Alcohol withdrawal and delirium tremens in the critically ill: A systematic review and commentary. Intensive Care Med 2013; 39:16-30
39. Neumann T, Gentilello LM, Neuner B, et al: Screening trauma patients with the alcohol use disorders identification test and biomarkers of alcohol use. Alcohol Clin Exp Res 2009; 33:970-976
40. Spies CD, Emadi A, Neumann T, et al: Relevance of carbohydratedeficient transferrin as a predictor of alcoholism in intensive care patients following trauma. J Trauma 1995; 39:742-748
41. Spies CD, Kissner M, Neumann T, et al: Elevated carbohydrate-deficient transferrin predicts prolonged intensive care unit stay in traumatized men. Alcohol Alcohol 1998; 33:661-669
42. van Munster BC, Korevaar JC, de Rooij SE, et al: Genetic polymorphisms related to delirium tremens: A systematic review. Alcohol Clin Exp Res 2007; 31:177-184
43. Maxson PM, Schultz KL, Berge KH, et al: Probable alcohol abuse or dependence: A risk factor for intensive-care readmission in patients undergoing elective vascular and thoracic surgical procedures. Mayo Perioperative Outcomes Group. Mayo Clin Proc 1999; 74: 448-453
44. Watson CG, Detra E, Fox KL, et al: Comparative concurrent validities of five alcoholism measures in a psychiatric hospital. J Clin Psychol 1995; 51:676-684
45. Dhalla S, Kopec JA: The CAGE questionnaire for alcohol misuse: A review of reliability and validity studies. Clin Invest Med 2007; 30:33-41
46. Sibley MH, Pelham WE Jr, Molina BS, et al: Diagnosing ADHD in adolescence. J Consult Clin Psychol 2012; 80:139-150
47. Spies CD, Dubisz N, Neumann T, et al: Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: Results of a prospective, randomized trial. Crit Care Med 1996; 24: 414-422
48. Tolonen J, Rossinen J, Alho H, et al: Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium. Eur J Emerg Med 2012 [Epub ahead of print]
49. Weinberg JA, Magnotti LJ, Fischer PE, et al: Comparison of intravenous ethanol versus diazepam for alcohol withdrawal prophylaxis in the trauma ICU: Results of a randomized trial. J Trauma 2008; 64:99-104
50. Gold JA, Rimal B, Nolan A, et al: A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med 2007; 35:724-730
51. Spies CD, Rommelspacher H: Alcohol withdrawal in the surgical patient: Prevention and treatment. Anesth Analg 1999; 88: 946-954
52. Ip Yam PC, Forbes A, Kox WJ: Clonidine in the treatment of alcohol withdrawal in the intensive care unit. Br J Anaesth 1992; 68: 106-108
53. McCowan C, Marik P: Refractory delirium tremens treated with propofol: A case series. Crit Care Med 2000; 28:1781-1784
54. Rayner SG, Weinert CR, Peng H, et al; Study Institution: Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Intensive Care 2012; 2:12
55. Muzyk AJ, Revollo JY, Rivelli SK: The use of dexmedetomidine in alcohol withdrawal. J Neuropsychiatry Clin Neurosci 2012; 24: E45-E46
56. Darrouj J, Puri N, Prince E, et al: Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal. Ann Pharmacother 2008; 42:1703-1705
57. Mayo-Smith MF: Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on pharmacological management of alcohol withdrawal. JAMA 1997; 278: 144-151
58. Amato L, Minozzi S, Vecchi S, et al: Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2010; 3:CD005063
59. Watling SM, Fleming C, Casey P, et al: Nursing-based protocol for treatment of alcohol withdrawal in the intensive care unit. Am J Crit Care 1995; 4:66-70
60. Barr J, Fraser GL, Puntillo K, et al; American College of Critical Care Medicine: Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41:263-306
61. Lexi-Comp IL-DL-C Medical software specializing in pharmacology. Available at: http://www.lexi.com. Accessed April 14, 2013
62. Wilkens L, Ruschulte H, Rückoldt H, et al: Standard calculation of ethanol elimination rate is not sufficient to provide ethanol substitution therapy in the postoperative course of alcohol-dependent patients. Intensive Care Med 1998; 24:459-463
63. Ungur LA, Neuner B, John S, et al: Prevention and therapy of alcohol withdrawal on intensive care units: Systematic review of controlled trials. Alcohol Clin Exp Res 2013; 37:675-686
64. Elsing C, Stremmel W, Grenda U, et al: Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: An open, single-center randomized study. Am J Drug Alcohol Abuse 2009; 35:189-192
65. Wilby MJ, Hutchinson PJ: The pharmacology of chlormethiazole: A potential neuroprotective agent? CNS Drug Rev 2004; 10:281-294
66. de Koning TJ, Duran M, Dorland L, et al: Beneficial effects of L-serine and glycine in the management of seizures in 3-phosphoglycerate dehydrogenase deficiency. Ann Neurol 1998; 44:261-265
67. Meyer JM: Chapter 16. Pharmacotherapy of psychosis and mania. In: Goodman & Gilman's the Pharmacological Basis of Therapeutics. Twelfth Edition. Brunton LLCB, Knollmann BC (Eds). New York, McGraw-Hill, 2011. Available at: http://www.accesspharmacy.com/content.aspx?aID=16663242. Accessed April 9, 2013
68. Rovasalo A, Tohmo H, Aantaa R, et al: Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: A case report. Gen Hosp Psychiatry 2006; 28:362-363
69. DeMuro JP, Botros DG, Wirkowski E, et al: Use of dexmedetomidine for the treatment of alcohol withdrawal syndrome in critically ill patients: A retrospective case series. J Anesth 2012; 26: 601-605
70. Blum K, Eubanks JD, Wallace JE, et al: Enhancement of alcohol withdrawal convulsions in mice by haloperidol. Clin Toxicol 1976; 9:427-434
71. Devlin JW, Al-Qadhee NS, Skrobik Y: Pharmacologic prevention and treatment of delirium in critically ill and non-critically ill hospitalised patients: A review of data from prospective, randomised studies. Best Pract Res Clin Anaesthesiol 2012; 26:289-309
72. Brunton LL, Chabner BA, Knollmann BC (Eds): Goodman & Gilman's the Pharmacological Basis of Therapeutics. Twelfth Edition. New York, McGraw-Hill, 2011. Available at: http://www.accesspharmacy. com/content.aspx?aID=16661344. Accessed April 9, 2013
73. Löscher W, Rogawski MA: How theories evolved concerning the mechanism of action of barbiturates. Epilepsia 2012; 53(Suppl 8):12-25
74. Bhana N, Goa KL, McClellan KJ: Dexmedetomidine. Drugs 2000; 59:263-269
75. Coursin DB, Coursin DB, Maccioli GA: Dexmedetomidine. Curr Opin Crit Care 2001; 7:221-226
76. Nechifor M: Magnesium in drug dependences. Magnes Res 2008; 21:5-15
77. Prior PL, Galduróz JC: Glutamatergic hyperfunctioning during alcohol withdrawal syndrome: Therapeutic perspective with zinc and magnesium. Med Hypotheses 2011; 77:368-370
78. Glue P, Nutt D: Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal. Br J Psychiatry 1990; 157:491-499
79. Wu C, Kenny MA: Circulating total and ionized magnesium after ethanol ingestion. Clin Chem 1996; 42:625-629
80. Elisaf M, Merkouropoulos M, Tsianos EV, et al: Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol 1995; 9:210-214
81. Kalbfleisch JM, Lindeman RD, Ginn HE, et al: Effects of ethanol administration on urinary excretion of magnesium and other electrolytes in alcoholic and normal subjects. J Clin Invest 1963; 42:1471-1475
82. Sechi G, Serra A: Wernicke's encephalopathy: New clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007; 6:442-455
83. Rubeiz GJ, Thill-Baharozian M, Hardie D, et al: Association of hypomagnesemia and mortality in acutely ill medical patients. Crit Care Med 1993; 21:203-209
84. Wilson A, Vulcano B: A double-blind, placebo-controlled trial of magnesium sulfate in the ethanol withdrawal syndrome. Alcohol Clin Exp Res 1984; 8:542-545
85. Jermain DM, Crismon ML, Nisbet RB: Controversies over the use of magnesium sulfate in delirium tremens. Ann Pharmacother 1992; 26:650-652
86. Thomson AD, Cook CC, Touquet R, et al; Royal College of Physicians, London: The Royal College of Physicians report on alcohol: Guidelines for managing Wernicke's encephalopathy in the accident and emergency department. Alcohol Alcohol 2002; 37:513-521
87. Isenberg-Grzeda E, Kutner HE, Nicolson SE: Wernicke-Korsakoffsyndrome: Under-recognized and under-treated. Psychosomatics 2012; 53:507-516
88. Thomson AD, Guerrini I, Marshall EJ: The evolution and treatment of Korsakoff's syndrome: Out of sight, out of mind? Neuropsychol Rev 2012; 22:81-92
89. Pierucci-Lagha A, Derouesné C: Alcoholism and aging. 2. Alcoholic dementia or alcoholic cognitive impairment? Psychol Neuropsychiatr Vieil 2003; 1:237-249
90. Holzbach E: Thiamine absorption in alcoholic delirium patients. J Stud Alcohol 1996; 57:581-584
91. World MJ, Ryle PR, Thomson AD: Alcoholic malnutrition and the small intestine. Alcohol Alcohol 1985; 20:89-124
92. Day E, Bentham P, Callaghan R, et al: Thiamine for Wernicke-Korsakoff syndrome in people at risk from alcohol abuse. Cochrane Database Syst Rev 2004; 1:CD004033
93. Ambrose ML, Bowden SC, Whelan G: Thiamin treatment and working memory function of alcohol-dependent people: Preliminary findings. Alcohol Clin Exp Res 2001; 25:112-116
94. Clark BJ, Moss M: Secondary prevention in the intensive care unit: Does intensive care unit admission represent a "teachable moment?" Crit Care Med 2011; 39:1500-1506
95. Møller AM, Maaløe R, Pedersen T: Postoperative intensive care admittance: The role of tobacco smoking. Acta Anaesthesiol Scand 2001; 45:345-348
96. Dubois MJ, Bergeron N, Dumont M, et al: Delirium in an intensive care unit: A study of risk factors. Intensive Care Med 2001; 27:1297-1304
97. Ouimet S, Kavanagh BP, Gottfried SB, et al: Incidence, risk factors and consequences of ICU delirium. Intensive Care Med 2007; 33:66-73
98. Van Rompaey B, Elseviers MM, Schuurmans MJ, et al: Risk factors for delirium in intensive care patients: A prospective cohort study. Crit Care 2009; 13:R77
99. Lucidarme O, Seguin A, Daubin C, et al: Nicotine withdrawal and agitation in ventilated critically ill patients. Crit Care 2010; 14:R58
100. Paolini M, De Biasi M: Mechanistic insights into nicotine withdrawal. Biochem Pharmacol 2011; 82:996-1007
101. De Biasi M, Dani JA: Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci 2011; 34:105-130
102. Gilbert DG, McClernon FJ, Rabinovich NE, et al: EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: Relations to depressive traits, nicotine exposure, and dependence. Exp Clin Psychopharmacol 1999; 7:427-443
103. Gilbert DG, McClernon FJ, Rabinovich NE, et al: Effects of smoking abstinence on mood and craving in men: Influences of negativeaffect-related personality traits, habitual nicotine intake and repeated measurements. Pers Individ Dif 1998; 25:399-423
104. Gilbert DG, McClernon FJ, Rabinovich NE, et al: Mood disturbance fails to resolve across 31 days of cigarette abstinence in women. J Consult Clin Psychol 2002; 70:142-152
105. Hughes JR: Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine Tob Res 2007; 9:315-327
106. Benowitz NL, Bernert JT, Caraballo RS, et al: Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 2009; 169:236-248
107. Etter JF, Vu Duc T, Perneger TV: Saliva cotinine levels in smokers and nonsmokers. Am J Epidemiol 2000; 151:251-258
108. Deveci SE, Deveci F, Açik Y, et al: The measurement of exhaled carbon monoxide in healthy smokers and non-smokers. Respir Med 2004; 98:551-556
109. Kork F, Neumann T, Spies C: Perioperative management of patients with alcohol, tobacco and drug dependency. Curr Opin Anaesthesiol 2010; 23:384-390
110. Neumann T, Neuner B, Weiss-Gerlach E, et al: Accuracy of carbon monoxide in venous blood to detect smoking in male and female trauma patients. Biomark Med 2008; 2:31-39
111. Heatherton TF, Kozlowski LT, Frecker RC, et al: The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86:1119-1127
112. Henningfield JE, Shiffman S, Ferguson SG, et al: Tobacco dependence and withdrawal: Science base, challenges and opportunities for pharmacotherapy. Pharmacol Ther 2009; 123:1-16
113. Rigotti NA, Munafo MR, Stead LF: Smoking cessation interventions for hospitalized smokers: A systematic review. Arch Intern Med 2008; 168:1950-1960
114. Joseph AM, Norman SM, Ferry LH, et al: The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996; 335:1792-1798
115. Kimmel SE, Berlin JA, Miles C, et al: Risk of acute first myocardial infarction and use of nicotine patches in a general population. J Am Coll Cardiol 2001; 37:1297-1302
116. Tzivoni D, Keren A, Meyler S, et al: Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther 1998; 12:239-244
117. Honisett TD: Nicotine replacement therapy for smokers admitted to intensive care. Intensive Crit Care Nurs 2001; 17:318-321
118. Mayer SA, Chong JY, Ridgway E, et al: Delirium from nicotine withdrawal in neuro-ICU patients. Neurology 2001; 57:551-553
119. Tran-Van D, Herve Y, Labadie P, et al: Restlessness in intensive care unit: Think to the nicotinic withdrawal syndrome. [French]. Ann Fr Anesth Reanim 2004; 23:604-606
120. Lee AH, Afessa B: The association of nicotine replacement therapy with mortality in a medical intensive care unit. Crit Care Med 2007; 35:1517-1521
121. Paciullo CA, Short MR, Steinke DT, et al: Impact of nicotine replacement therapy on postoperative mortality following coronary artery bypass graft surgery. Ann Pharmacother 2009; 43: 1197-1202
122. Cartin-Ceba R, Warner DO, Hays JT, et al: Nicotine replacement therapy in critically ill patients: A prospective observational cohort study. Crit Care Med 2011; 39:1635-1640
123. Gillies MA, McKenzie CA, Whiteley C, et al: Safety of nicotine replacement therapy in critically ill smokers: A retrospective cohort study. Intensive Care Med 2012; 38:1683-1688
124. Zhang Z, Pan L, Ni H: Impact of delirium on clinical outcome in critically ill patients: A meta-analysis. Gen Hosp Psychiatry 2013; 35:105-111
125. Cinciripini PM, Robinson JD, Karam-Hage M, et al: Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal. JAMA Psychiatry 2013; 70:522-533
126. Yamada H, Bruijnzeel AW: Stimulation of r2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats. Neuropharmacology 2011; 60:303-311
127. Gourlay S, Forbes A, Marriner T, et al: A placebo-controlled study of three clonidine doses for smoking cessation. Clin Pharmacol Ther 1994; 55:64-69
128. Franks P, Harp J, Bell B: Randomized, controlled trial of clonidine for smoking cessation in a primary care setting. JAMA 1989; 262:3011-3013
129. Cammarano WB, Pittet JF, Weitz S, et al: Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med 1998; 26:676-684
130. Birchley G: Opioid and benzodiazepine withdrawal syndromes in the paediatric intensive care unit: A review of recent literature. Nurs Crit Care 2009; 14:26-37
131. Devlin JW, Mallow-Corbett S, Riker RR: Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med 2010; 38:S231-S243
132. Skrobik Y: Counterpoint: Should benzodiazepines be avoided in mechanically ventilated patients? No. Chest 2012; 142:284-287
133. Skrobik Y, Leger C, Cossette M, et al: Factors predisposing to coma and delirium: Fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. Crit Care Med 2013; 41:999-1008
134. Riker RR, Shehabi Y, Bokesch PM, et al; SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group: Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009; 301:489-499
135. Sullivan JT, Sykora K, Schneiderman J, et al: Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989; 84:1353-1357